Research Article
BibTex RIS Cite

Year 2005, , 0 - 0, 01.01.2005

Yıldız Güney

https://doi.org/10.1501/Ashd_0000000057

Abstract

References

  • Ankara Üniversitesi – Ankara Sağlık Hizmetleri Dergisi - ASHD

Hyperfractionated Radiotherapy in Malignant Astrocytomas

Year 2005, , 0 - 0, 01.01.2005

Yıldız Güney

https://doi.org/10.1501/Ashd_0000000057

Abstract

Purpose: Afler convcntional doses of 55 10 65 Gy of fractionaled irradiation. anaplastic astrocytoma (AA) and gtiobla.s(on)a ınultitbrme (GBM) usually recur aı us orginal location. The preseni sludy was designcd lo deternıinc whclher hyperfraciionaıed radiolherapy (IIPRT) woııld improve local luınor control and patients' survival. Also Ihe factors effeeting thc prognosis in high gradc asirocyıoma weredetecicd.
Conciusion; Although we obscrved prolonged survival ın our study compared wiıh the convcntional radiothcrapy results in the literatüre, hard to say it is relaled lo HF'RT dııe to small number of patients. Our sludy gives an idca ihal HFRT can be easily applied and side effects are well toleraled.
Kcy Words: Radiolherapy; hyperfrac- lionated, malign asirocylomas.
Materials and Methods; Bclwecn Decemher 1994 and January 1996, 24 patients wcre cnrolled to a prospeclive study. Patients were hislologically confirmed wiıh AA and GBM and previously untreaıed. A total dose of 69.6 G)' was delivered in 1.2 Gy fraclions twice daily with an inter\'al of 6 to 8 hours. 5 days per week. Clinical Target Volüme (CT\0 was established as Gross Tumor Volüme (GTV) plu.s 2-2.5 cm and 05 cm was added xs safety margin for Pknning Target Volüme (PT\0-

Keywords

malign asirocylomas Radiotherapy Hyperfractionated

References

  • Ankara Üniversitesi – Ankara Sağlık Hizmetleri Dergisi - ASHD
There are 1 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Miscellaneous
Authors

Yıldız Güney This is me

Publication Date January 1, 2005
Submission Date January 1, 2005
Published in Issue Year 2005

Cite

APA Güney, Y. (2005). Hyperfractionated Radiotherapy in Malignant Astrocytomas. Ankara Sağlık Hizmetleri Dergisi, 7(1). https://doi.org/10.1501/Ashd_0000000057
AMA Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. January 2005;7(1). doi:10.1501/Ashd_0000000057
Chicago Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi 7, no. 1 (January 2005). https://doi.org/10.1501/Ashd_0000000057.
EndNote Güney Y (January 1, 2005) Hyperfractionated Radiotherapy in Malignant Astrocytomas. Ankara Sağlık Hizmetleri Dergisi 7 1
IEEE Y. Güney, “Hyperfractionated Radiotherapy in Malignant Astrocytomas”, ASHD, vol. 7, no. 1, 2005, doi: 10.1501/Ashd_0000000057.
ISNAD Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi 7/1 (January 2005). https://doi.org/10.1501/Ashd_0000000057.
JAMA Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. 2005;7. doi:10.1501/Ashd_0000000057.
MLA Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi, vol. 7, no. 1, 2005, doi:10.1501/Ashd_0000000057.
Vancouver Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. 2005;7(1).